Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
NervGen Pharma Corp
NGENF
Primary Symbol:
V.NGEN
Healthcare
NervGen Pharma Corp. is a clinical-stage biotech company. The Company is engaged in discovery, development and commercialization of pharmaceutical products for the treatment of nervous system damage due to injury or disease. The Company is advancing its lead compound, NVG-291, for the treatment of spinal cord injury (SCI), Alzheimer’s disease (AD) and multiple sclerosis (MS). Its NVG-291 is a...
therapeutic peptide, which is a mimetic of the intracellular domain of protein tyrosine phosphatase, a cell surface receptor known to interact with chondroitin sulfate proteoglycans (CSPGs) and to be involved in the regulation of neuroplasticity and central nervous system repair. It has also initiated preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury. The Company's wholly owned subsidiaries include NervGen US Inc. and NervGen Australia Pty Ltd.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:NGEN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
Next
(16)
•••
stargazer1
X
View Profile
View Bullboard History
Post by
stargazer1
on Feb 02, 2024 6:17pm
Wowza Wowza Pay attention before it's too late!
NervGen Pharma Corp. (NGENF) Things are happening behind the scenes. 2.5900 + 0.4150 (+19.0805%) volume 105,701 At close: 4 PM EST $2.61 + $0.4334 (+19.93%) volume post
...more
(16)
•••
stargazer1
X
View Profile
View Bullboard History
Post by
stargazer1
on Feb 01, 2024 12:41pm
NGENF to be top biotech of 2024. Clinical trial results leak
This could be the signal that tiny NervGen Pharma Corp. NGENF is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(3)
•••
RHertig
X
View Profile
View Bullboard History
Comment by
RHertig
on Jan 29, 2024 6:14pm
RE:Big boys have stopped buying. What it means.
I have a big chunk of shares. I plan to hold thru all the trials. I can answer the big jump mystery. There was a big pump on Reddit.
(2)
•••
rdgeo44
X
View Profile
View Bullboard History
Post by
rdgeo44
on Jan 10, 2024 5:43pm
To the moon Stargazer!! To the moon.
Love your positive post SG. I believe you are so right but whether this is a $1000 stock is questionable. Your comment that we need another positive press release if only to say " progress is
...more
(16)
•••
stargazer1
X
View Profile
View Bullboard History
Post by
stargazer1
on Jan 10, 2024 2:32pm
Next press release should be good. LowMoor, a question
From the press releases that have been released, all results are positive. The next press release will probably be an update on how the trials are progressing. If it is better than expected, the stock
...more
(35)
•••
LowMoor
X
View Profile
View Bullboard History
Post by
LowMoor
on Jan 09, 2024 9:35am
Up we go again today. Insider buying. Positive news expected
New presentation. https://nervgen.com/wp-content/uploads/2024/01/1-NervGen-Presentation-20240104-web.pdf
(35)
•••
LowMoor
X
View Profile
View Bullboard History
Post by
LowMoor
on Jan 08, 2024 2:18pm
Insider buy today, a small amount. But its a buy.
Filed 2024-01-08 13:59 Tx date 2024-01-08 $NGEN NervGen Pharma Corp. McKerracher, Krista 4 - Director of Issuer Direct Ownership
...more
(35)
•••
LowMoor
X
View Profile
View Bullboard History
Comment by
LowMoor
on Jan 08, 2024 1:53pm
RE:Under $2, But: SHOOTING UPWARD 2 days now. Buy? Buy?
I bought a few. Where can this go if the drug works. $50 ?
(16)
•••
stargazer1
X
View Profile
View Bullboard History
Post by
stargazer1
on Jan 08, 2024 11:16am
Under $2, But: SHOOTING UPWARD 2 days now. Buy? Buy?
So far no new press release. NGENF has fallen for days and days since it went up on hugh volumes. After the hugh volumes, it has been dropping on volumes of a few thousand shares. But now volume is
...more
(16)
•••
stargazer1
X
View Profile
View Bullboard History
Post by
stargazer1
on Dec 31, 2023 3:08pm
When Big Institutions can buy NGENF. Then it goes ballistic.
rdgeo44 you were right. Even though NervGen's primary focus was on the regeneration of damaged spinal cord neurons, its drug, NVG-291, also induces the repair of the scar tissue that envelopes the
...more
(16)
•••
stargazer1
X
View Profile
View Bullboard History
Post by
stargazer1
on Dec 30, 2023 8:14pm
Big boys have stopped buying. What it means.
rdge44 thanks for the kind words. When it comes to MS, I think that there may be hope. Last week literally millions of shares were bought in just a few days. Buying continued through the first half of
...more
(2)
•••
rdgeo44
X
View Profile
View Bullboard History
Comment by
rdgeo44
on Dec 28, 2023 1:48pm
RE:Goodness
Well Stargazer, hope you are right, not only on the money side but on the altruistic side as well. We have a daughter who suffers from MS and this drug might be the silver bullet we have prayed for to
...more
(16)
•••
stargazer1
X
View Profile
View Bullboard History
Post by
stargazer1
on Dec 27, 2023 3:43pm
Goodness
Two years ago, November 2021, the stock reached an all time high of $2.49. We have reached $2.23 already, on almost a quarter of a million shares traded. Yesterday we were in the $1 range. We
...more
(16)
•••
stargazer1
X
View Profile
View Bullboard History
Post by
stargazer1
on Dec 27, 2023 3:22pm
# neuron injury cases USA + global & its effect on stock's $
Spinal Cord Injury: USA: 300,000 people with spinal cord injury. 18,000 new cases yearly.
...more
(16)
•••
stargazer1
X
View Profile
View Bullboard History
Post by
stargazer1
on Dec 27, 2023 12:10pm
NO ONE ELSE HAS A DRUG TO REPAIR CRUSED, SEVERED NEURONS
If our drug works, AND IT WORKED ON ANIMALS, well people say that I'm an animal, they do call me a pig, so that means that it will work on people? Well, whatever, ALL INDICATIONS are that it will
...more
Prev
1
2
3
4
5
6
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >